When was Inocras founded?

Inocras was founded in 2020 and raised its 1st funding round within a year of its incorporation.

Where is Inocras located?

Inocras is headquartered in San Diego, United States.

How many employees does Inocras have?

As of Jun 30, 2025, the latest employee count at Inocras is 84.

Is Inocras a funded company?

Inocras is a funded company, having raised a total of $100M across 6 funding rounds to date. The company's 1st funding round was a $***** Grant (prize money) round, raised on 2020.

When was the latest funding round of Inocras?

Inocras' latest funding was a $***** Series B round on Aug 03, 2026, with participation from 9 investors. Its primary sector is Healthcare IT. In United States, the Healthcare IT sector has seen $5.36B in funding in 2026 to date.

Where does Inocras rank among its competitors?

Inocras ranks 3rd amongst 26 active competitors, of which 6 are funded. It stands 3rd in terms of total funding among its competitors. The most recent competitor to raise funding was Inocras, which secured $31M in Aug, 2026.

Who are the top competitors of Inocras?

Inocras' top competitors include Sophia Genetics, NeuroKaire and Karius. Among them, Inocras secured the most recent funding round in August, 2026.

Inocras - 2026 Company Profile, Team, Funding & Competitors

Company Details

AI-driven platform provides whole genome insights for cancer and rare diseases. It has developed an IP-protected technology and proprietary whole genome insight platform to improve patient diagnosis and treatment by unlocking the full potential of genomic data.

Website: inocras.com
Social
Email ID: *****@inocras.com
Phone Number: +1 **********

Key Metrics

Founded Year

2020

Location

San Diego, United States

Stage

Series B

Total Funding

$100M in 6 rounds

Latest Funding Round

Series B, Aug 03, 2026, $*****

Investors

Samsung Venture Investment & 20 more

Ranked

3^rd among 26 active competitors

Employee Count

84 as on Jun 30, 2025

Similar Companies

Sophia Genetics & 25 more

View Inocras' full profile

Inocras is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Inocras Inc CIN: 87-4609338 , United States, Active	May 24, 2024	-	27 (As on Jun 30, 2025)	-

Inocras has raised a total funding of $100M over 6 rounds. Its first funding round was on 2020. Its latest funding round was a Series B round on Aug 03, 2026 for $*****. 9 investors participated in its latest round. Inocras has 21 institutional investors.

Here is the list of recent funding rounds of Inocras:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Aug 03, 2026	5070424	Series B	8112211	3946149	6612184	3638130
Dec 05, 2024	7489093	Series B	9833075	7595084	4612530	Big Move Ventures
Nov 01, 2023	5383482	Series B	9568664	7963882	Samsung Venture Investment & 4 more	InterVest & 4 more

Access funding benchmarks and valuations. Sign up today!

View details of Inocras's funding rounds and investors

The founders of Inocras is Jeong Seok Lee. Jehee Suh is the CEO of Inocras.

Here are the details of Inocras' key team members:

Jeong Seok Lee: Co-Founder & Chief Innovation Officer of Inocras.
Contact Info: 1 email address
Jehee Suh: CEO of Inocras.
Contact Info: 1 email address

View details of Inocras's Founder profiles and Board Members

Inocras' employee count trend

Inocras has 84 employees as of Jun 25. Here is Inocras's employee count trend over the years:

Uncover Inocras' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Inocras include Sophia Genetics, NeuroKaire and Karius. Here is the list of Top 10 competitors of Inocras, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Sophia Genetics 2011, Rolle (Switzerland), Public	Provider of artificial intelligence software for analyzing complex medical data	$249M	Generation Investment Management, Endeavour Vision ... & 24 others	62/100
2nd	NeuroKaire 2017, Kearny (United States), Series A	Platform offering personalized treatment for psychiatric and neurological conditions	$20M	GreyBird Ventures, Meron Capital & 6 others	61/100
3rd	Inocras 2020, San Diego (United States), Series B	AI-driven platform provides whole genome insights for cancer and rare diseases	$100M	Samsung Venture Investment, DT&Investment ... & 19 others	58/100
4th	Karius 2014, Redwood City (United States), Series C	Provider of diagnostics for identifying infectious diseases using microbial DNA	$315M	Khosla Ventures, Gilde Healthcare & 16 others	58/100
5th	Emedgene 2015, Tel Aviv (Israel), Series A	Knowledge management platform to support genetic tests' decision	$6M	OTV, Microsoft & 7 others	47/100
6th	Elypta 2017, Stockholm (Sweden), Series A	Provider of liquid biopsy-based molecular diagnostics for cancer detection	$27.9M	Industrifonden, Bonnier Capital & 12 others	44/100
7th	Qnomx 2024, Basel (Switzerland), Seed	Provider of AI-powered genomic data interpretation platform	$1.93M	better ventures, Springboard Health Angels ... & 5 others	33/100
8th	Artificial Intelligence Expert 2019, Cluj napoca (Romania), Funding Raised	Provider of AI-based oncology test	-	EIC Fund, Europa	31/100
9th	Candida.app 2024, Helsinki (Finland), Unfunded	Provider of a web-based application that provides tools for analyzing Candida auris genomes	-	-	30/100
10th	AIR Genomics 2024, Carbajosa De La Sagrada (Spain), Unfunded	AI based solutions for automating the workflow of gene analyses and assisting in diagnostic procedures	-	-	30/100